NeOnc, Inc — a biotech company headed by neurosurgeon Dr. Thomas Chen — has developed a nasal brain delivery system that transports medications via a cranial-to-brain delivery, bypassing the ...

Biotech company NeOnc has developed a new drug delivery system that just might revolutionize the lives of brain cancer patients When it comes to treating cancer, the world has come a long way.

There’s precedent for intranasal drug delivery to hit central nervous system targets. Some migraine drugs work this way.NeOnc’s drug, NEO100, leverages cranial nerves in the brain, Chen said.

Business. A biotech company aiming for permanent brain implants buys Addison foundry The facility makes thin strips of film that measure electrical activity when placed against the brain’s ...